Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockholm with first day of trading on 24 September 2019.
Vinge advises Vicore Pharma Holding AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market.
The Norwegian energy company Equinor ASA announced on 7 July that it had agreed with Lundin Petroleum AB (publ) to divest around 54.5 million shares in Lundin Petroleum for a total consideration of around USD 1.56 billion and to acquire 2.6% of the development project Johan Sverdrup for a cash consideration of USD 910 million.
The Board of Directors of Calliditas Therapeutics AB (publ) (“Calliditas”) has resolved on a directed new issue of shares, whereby the company will raise proceeds of approximately SEK 210 million, before issue costs.
Vinge has acted for Bergs Timber in connection with its acquisition of all shares in AB Fågelfors Hyvleri, a company with wood pellet production located in Fågelfors, Sweden.
The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 727 million, before issue costs.
Vinge has advised Ambea AB (publ) on a fully subscribed rights issue, which will provide Ambea with issue proceeds amounting to approximately SEK 1,215 million before costs.
Veoneer, Inc. (“Veoneer”) has completed a USD 600 million capital raise, consisting of two concurrent offerings of USD 420 million of shares of common stock and USD 180 million aggregate principal amount of convertible senior notes due 2024.
Vinge has advised the fintech company Anyfin AB in connection with an investment round of approximately MSEK 80, in which new and existing investors are participating including, among others, Accel, Northzone, Global Founders Capital and Fintech Collective.
The board of directors of Jays Group AB (publ) has resolved pursuant to authorization granted at an annual general meeting to perform a new issue of shares amounting to approximately MSEK 41 subject to pre-emption rights for the company’s existing shareholders.
Creades AB (publ) has sold 4,250,000 shares in Lindab International AB (publ) at SEK 100 per share (in total SEK 425 million) through an accelerated bookbuilt offering to institutional investors.
